Case number 2016-1455
Palmetto Pharmaceuticals LLC v. AstraZeneca Pharmaceuticals > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | PALMETTO PHARMACEUTICALS LLC v. ASTRAZENECA PHARMACEUTICALS [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Jan 19, 2017 | 55 | Mandate issued to the United States District Court for the District of South Carolina. Service as of this date by Clerk of Court. [400244] [16-1455, 16-1501] [JCA] [Entered: 01/19/2017 08:43 AM] (1) |
| Dec 9, 2016 | 54 | OPINION and JUDGMENT filed. The judgment or decision is: Affirmed. (FCR 36). (For the Court: Moore,Circuit Judge; Wallach,Circuit Judge and Chen,Circuit Judge). [389700] [16-1455, 16-1501] [CAB] [Entered: 12/09/2016 09:55 AM] (5) |
| Dec 7, 2016 | 53 | Submitted after ORAL ARGUMENT by Mr. John Paul Isacson, Esq. for Palmetto Pharmaceuticals LLC and Mr. Christopher Neil Sipes, Esq. for AstraZeneca Pharmaceuticals LP. Panel: Judge: Moore , Judge: Wallach , Judge: Chen. [388900] [JCP] [Entered: 12/07/2016 10:28 AM] (0) |
| Nov 15, 2016 | 52 | Response to oral argument order from the Cross-Appellant AstraZeneca Pharmaceuticals LP. designating Christopher N. Sipes as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [383068] [Christopher Sipes] [Entered: 11/15/2016 10:55 AM] (0) |
| Nov 15, 2016 | 51 | Response to oral argument order from the Appellant Palmetto Pharmaceuticals LLC. designating John P. Isacson as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [383046] [John Isacson] [Entered: 11/15/2016 10:24 AM] (0) |
| Oct 21, 2016 | 50 | NOTICE OF CALENDARING. Panel: 1612J. Case scheduled Dec 07, 2016 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 203. Response to oral argument order due: 11/15/2016. Counsel should check-in 30 minutes prior to the opening of the session. Please review the Oral Argument Order. [376568] THIS NOTICE APPLIES TO CASE(S): [16-1306, 16-1455, 16-1601, 16-1617] [JAB] [Entered: 10/21/2016 01:12 PM] (0) |
| Aug 15, 2016 | 49 | 6 paper copies of the Joint Appendix [45] received from Appellant Palmetto Pharmaceuticals LLC. [358870] [KW] [Entered: 08/15/2016 03:25 PM] (0) |
| Aug 15, 2016 | 48 | Notice from Cross-Appellant AstraZeneca Pharmaceuticals LP regarding conflicts with oral argument (Potential conflict with oral argument yet to be scheduled in ArcelorMittal, et al. v. AK Steel Corp., et al. (No. 16-1357).). Service: 08/15/2016 by email. [358773] [Christopher Sipes] [Entered: 08/15/2016 01:04 PM] (2) |
| Aug 15, 2016 | 47 | Notice from Appellant Palmetto Pharmaceuticals LLC regarding conflicts with oral argument (None). Service: 08/15/2016 by email. [358707] [David Harth] [Entered: 08/15/2016 11:31 AM] (1) |
| Aug 8, 2016 | 46 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 08/15/2016. [357020] [JCA] [Entered: 08/08/2016 04:11 PM] (0) |
| Aug 8, 2016 | 45 | APPENDIX FILED for Palmetto Pharmaceuticals LLC [43]. Number of Pages: 575. Service: 08/08/2016 by email. Pursuant to Fed. Cir. R. 30(a)(5), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/15/2016. [356972] [JCA] [Entered: 08/08/2016 03:26 PM] (575) |
| Aug 8, 2016 | 44 | Statement of Compliance with Fed. Cir. R. 33 for Appellant Palmetto Pharmaceuticals LLC. Service: 08/08/2016 by email. [356945] [David Harth] [Entered: 08/08/2016 02:51 PM] (4) |
| Aug 8, 2016 | 43 | TENDERED from Appellant Palmetto Pharmaceuticals LLC. Title: JOINT APPENDIX. Service: 08/08/2016 by email. [356938] [David Harth] [Entered: 08/08/2016 02:44 PM] (575) |
| Aug 3, 2016 | 42 | 6 paper copies of the Reply Brief [41] received from Cross-Appellant AstraZeneca Pharmaceuticals LP. [355846] [KW] [Entered: 08/03/2016 02:21 PM] (0) |
| Jul 29, 2016 | 41 | REPLY BRIEF FILED for Cross-Appellant AstraZeneca Pharmaceuticals LP [40]. Number of Pages: 15. Service: 07/29/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 08/08/2016. Appendix is due 08/08/2016. [355244] [JB] [Entered: 08/02/2016 08:47 AM] (24) |
| Jul 29, 2016 | 40 | TENDERED from Cross-Appellant AstraZeneca Pharmaceuticals LP. Title: REPLY BRIEF. Service: 07/29/2016 by email. [354792] [Christopher Sipes] [Entered: 07/29/2016 06:39 PM] (24) |
| Jul 5, 2016 | 38 | **TEXT ONLY** ORDER granting motion to extend time to file cross-appellant's reply brief [37] filed by Cross-Appellant AstraZeneca Pharmaceuticals LP Cross-Appellant's reply brief due 07/29/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [348266] [JB] [Entered: 07/05/2016 09:23 AM] (0) |
| Jul 1, 2016 | 39 | 6 paper copies of the Reply Brief [36] received from Appellant Palmetto Pharmaceuticals LLC. [348420] [JCP] [Entered: 07/05/2016 01:44 PM] (0) |
| Jul 1, 2016 | 37 | MOTION of Cross-Appellant AstraZeneca Pharmaceuticals LP to extend the time to 07/29/2016 to file the cross-appellant's reply brief. Response/Opposition is due 07/14/2016 [Consent: unopposed]. Service: 07/01/2016 by email. [348186] [Isaac Belfer] [Entered: 07/01/2016 04:23 PM] (6) |
| Jun 28, 2016 | 36 | REPLY BRIEF FILED for Appellant Palmetto Pharmaceuticals LLC [35]. Number of Pages: 37. Service: 06/28/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 07/05/2016. Cross-Appellant's reply brief is due 07/15/2016. [347654] [JB] [Entered: 06/30/2016 10:33 AM] (39) |
| Jun 28, 2016 | 35 | TENDERED from Appellant Palmetto Pharmaceuticals LLC. Title: REPLY BRIEF. Service: 06/28/2016 by email. [347159] [David Harth] [Entered: 06/28/2016 05:05 PM] (39) |
| May 23, 2016 | 34 | 6 paper copies of the Opening and Response Brief [32] received from Cross-Appellant AstraZeneca Pharmaceuticals LP. [338645] [MJL] [Entered: 05/26/2016 10:20 AM] (0) |
| May 20, 2016 | 33 | Clerk's Note to the File: Appellant Palmetto Pharmaceuticals LLC reply brief is due 07/01/2016. [337184] --[Edited 05/20/2016 by clerk to correct the due date of the appellant's reply brief] [JB] [Entered: 05/20/2016 01:59 PM] (0) |
| May 19, 2016 | 32 | BRIEF FILED for Cross-Appellant AstraZeneca Pharmaceuticals LP [31]. Number of Pages: 55. Service: 05/19/2016 by email. Pursuant to Fed. Cir. R. 31(b), filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 05/25/2016. Appellant Palmetto Pharmaceuticals LLC reply brief is due 07/01/2016. [337103] --[Edited 05/20/2016 by clerk to correct the due date of the appellant's reply brief] [JB] [Entered: 05/20/2016 12:03 PM] (67) |
| May 19, 2016 | 31 | TENDERED from Cross-Appellant AstraZeneca Pharmaceuticals LP. Title: RESPONSE BRIEF. Service: 05/19/2016 by email. [336984] [Christopher Sipes] [Entered: 05/19/2016 10:58 PM] (67) |
| May 16, 2016 | 30 | Entry of appearance for Isaac C. Belfer as of counsel for Cross-Appellant AstraZeneca Pharmaceuticals LP. Service: 05/16/2016 by email. [335499] [Isaac Belfer] [Entered: 05/16/2016 04:00 PM] (2) |
| Mar 30, 2016 | 29 | **TEXT ONLY** ORDER granting motion to extend time to file appellee/respondent/cross-appellant principal brief [28] filed by Cross-Appellant AstraZeneca Pharmaceuticals LP. Cross-Appellant AstraZeneca Pharmaceuticals LP brief due 05/19/2016. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [322724] [JCA] [Entered: 03/30/2016 09:06 AM] (0) |
| Mar 29, 2016 | 28 | MOTION of Cross-Appellant AstraZeneca Pharmaceuticals LP to extend the time to 05/19/2016 to file the appellee/respondent/cross-appellant's principal brief. Response/Opposition is due 04/11/2016 [Consent: unopposed]. Service: 03/29/2016 by email. [322666] [Robert Fowler] [Entered: 03/29/2016 05:46 PM] (6) |
| Mar 28, 2016 | 27 | 6 paper copies of the Opening Brief [25] received from Appellant Palmetto Pharmaceuticals LLC. [322546] [LAJ] [Entered: 03/29/2016 03:25 PM] (0) |
| Mar 25, 2016 | 26 | 6 paper copies of the Opening Brief [25] received from Appellant Palmetto Pharmaceuticals LLC. [322161] [LAJ] [Entered: 03/28/2016 03:06 PM] (0) |
| Mar 23, 2016 | 25 | BRIEF FILED for Appellant Palmetto Pharmaceuticals LLC [24]. Number of Pages: 35. Service: 03/23/2016 by email. Pursuant to ECF-10, filer is directed to file six copies of the brief in paper format. The paper copies of the brief should be received by the court on or before 03/29/2016. Cross-Appellant AstraZeneca Pharmaceuticals LP brief is due 05/05/2016. [321350] [JB] [Entered: 03/24/2016 09:25 AM] (138) |
| Mar 23, 2016 | 24 | TENDERED from Appellant Palmetto Pharmaceuticals LLC. Title: OPENING BRIEF. Service: 03/23/2016 by email. [321168] [David Harth] [Entered: 03/23/2016 03:02 PM] (138) |
| Mar 21, 2016 | 23 | Entry of appearance for John P. Isacson as of counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 03/21/2016 by email. [320279] [David Pekarek Krohn] [Entered: 03/21/2016 11:41 AM] (2) |
| Mar 21, 2016 | 22 | Corrected Entry of appearance for Colin G. Sandercock as of counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 03/21/2016 by email. [320234] [Colin Sandercock] [Entered: 03/21/2016 10:26 AM] (2) |
| Mar 21, 2016 | 21 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [20] filed by Appellant Palmetto Pharmaceuticals LLC in 16-1455 is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [320188] [JB] [Entered: 03/21/2016 08:43 AM] (0) |
| Mar 17, 2016 | 20 | Entry of appearance for Colin G. Sandercock as of counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 03/17/2016 by email. [319829] [Colin Sandercock] [Entered: 03/17/2016 04:40 PM] (0) |
| Mar 4, 2016 | 19 | **TEXT ONLY** ORDER granting motion to extend time to file appellant/petitioner principal brief [17] filed by Appellant Palmetto Pharmaceuticals LLC Brief due 03/25/2016.. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [315989] [JB] [Entered: 03/04/2016 01:36 PM] (0) |
| Mar 4, 2016 | 18 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a), Fed. Cir. R. 47.3 and ECF-2(E) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [315986] [JB] [Entered: 03/04/2016 01:31 PM] (0) |
| Mar 4, 2016 | 17 | MOTION of Appellant Palmetto Pharmaceuticals LLC to extend the time to 03/25/2016 at 11:59 pm to file the appellant/petitioner's principal brief. Response/Opposition is due 03/17/2016 [Consent: unopposed]. Service: 03/04/2016 by email. [315894] [David Harth] [Entered: 03/04/2016 09:54 AM] (5) |
| Feb 25, 2016 | 16 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Palmetto Pharmaceuticals LLC. Service: 02/25/2016 by email. [313896] [David Harth] [Entered: 02/25/2016 12:10 PM] (2) |
| Feb 2, 2016 | 15 | Certificate of Compliance with Fed. R. App. P. 10(b) [The Transcript of Proceedings] for Appellant Palmetto Pharmaceuticals LLC. Service: 02/02/2016 by email. [307793] [David Harth] [Entered: 02/02/2016 11:39 AM] (2) |
| Jan 26, 2016 | 14 | Entry of appearance for R. Jason Fowler as of counsel for Cross-Appellant AstraZeneca Pharmaceuticals LP. Service: 01/25/2016 by email. [305632] [Robert Fowler] [Entered: 01/25/2016 04:42 PM] (2) |
| Jan 26, 2016 | 13 | Entry of appearance for Stephen P. Anthony as of counsel for Cross-Appellant AstraZeneca Pharmaceuticals LP. Service: 01/25/2016 by email. [305631] [Stephen Anthony] [Entered: 01/25/2016 04:39 PM] (2) |
| Jan 26, 2016 | 12 | Docketing Statement for the Cross-Appellant AstraZeneca Pharmaceuticals LP. Service: 01/25/2016 by email. [305630] [Christopher Sipes] [Entered: 01/25/2016 04:36 PM] (3) |
| Jan 26, 2016 | 11 | Certificate of Interest for the Cross-Appellant AstraZeneca Pharmaceuticals LP. Service: 01/25/2016 by email. [305627] [Christopher Sipes] [Entered: 01/25/2016 04:35 PM] (3) |
| Jan 26, 2016 | 10 | Entry of appearance for Christopher N. Sipes as principal counsel for Cross-Appellant AstraZeneca Pharmaceuticals LP. Service: 01/25/2016 by email. [305626] [Christopher Sipes] [Entered: 01/25/2016 04:32 PM] (2) |
| Jan 26, 2016 | 9 | Entry of appearance for Dan L. Bagatell as of counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 01/25/2016 by email. [305620] [Dan Bagatell] [Entered: 01/25/2016 03:44 PM] (2) |
| Jan 26, 2016 | 8 | Docketing Statement for the Appellant Palmetto Pharmaceuticals LLC. Service: 01/25/2016 by email. [305613] [David Harth] [Entered: 01/25/2016 03:27 PM] (3) |
| Jan 26, 2016 | 7 | Certificate of Interest for the Appellant Palmetto Pharmaceuticals LLC. Service: 01/25/2016 by email. [305611] [David Harth] [Entered: 01/25/2016 03:25 PM] (3) |
| Jan 26, 2016 | 6 | Entry of appearance for David R. Pekarek Krohn as of counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 01/25/2016 by email. [305609] [David Pekarek Krohn] [Entered: 01/25/2016 03:23 PM] (2) |
| Jan 26, 2016 | 5 | Entry of appearance for John S. Skilton as of counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 01/25/2016 by email. [305608] [John Skilton] [Entered: 01/25/2016 03:21 PM] (2) |
| Jan 26, 2016 | 4 | Entry of appearance for David J. Harth as principal counsel for Appellant Palmetto Pharmaceuticals LLC. Service: 01/25/2016 by email. [305607] [David Harth] [Entered: 01/25/2016 03:18 PM] (2) |
| Jan 20, 2016 | 3 | Official caption revised Cross-Appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by Clerk of Court. [304739] [JB] [Entered: 01/20/2016 02:50 PM] (0) |
| Jan 20, 2016 | 2 | Note to file: The following cases are associated:16-1455 Lead with 16-1501 Cross-Appeal. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [304734] [JB] [Entered: 01/20/2016 02:43 PM] (0) |
| Jan 11, 2016 | 1 | Appeal docketed. Received: 01/07/2016. [301550]Entry of Appearance due 01/25/2016. Certificate of Interest is due on 01/25/2016. Docketing Statement due 01/25/2016. Appellant/Petitioner's brief is due 03/11/2016. [JB] [Entered: 01/11/2016 09:33 AM] (61) |
